Event

M-CERSI Conference on Patient-Focused Drug Development

Monday, March 9, 2015
8:30 a.m.-5:00 p.m.
Hyatt Regency Hotel, Bethesda, MD
Ann Anonsen
301 405 0285
aanonsen@umd.edu

About the Event:

The M-CERSI Conference on Patient-Focused Drug Development will be held on Monday, March 9, 2015 at the Hyatt Regency Hotel in Bethesda, MD. The conference will provide a forum for all patient-focused drug development (PFDD) stakeholders to gather for an open dialogue. Patients, caregivers, and patient advocacy groups, as well as regulators from the Food and Drug Administration (FDA); researchers from academia, industry, and other agencies; payers; and other stakeholders will come together to discuss the following topics:

• Definition of PFDD
• Essential components that need to be included in successful PFDD
• Current initiatives, such as those of the FDA, patient advocacy groups, and pharmaceutical companies
• Challenges to achieving PFDD and methods to overcome those challenges
• Recommendations on a plan of action that includes a description of stakeholders' roles to move PFDD forward

Workshop will examine current practices and applications of pediatric exposure matching and pediatric exposure-response analysis from variety of perspectives with special attention to recommendations for application of these practices in drug development.

For additional information: http://www.pharmacy.umaryland.edu/centers/cersievents/patient-focused-drug-development/